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Abstract: In this paper, we evaluate the closed-loop performance of a control algorithm for the
treatment of type 1 diabetes (T1D) identified from prior continuous glucose monitor (CGM)
data. The control algorithm is based on nonlinear model predictive control (NMPC). At each
iteration, we solve an optimal control problem (OCP) using a sequential quadratic programming
algorithm with multiple shooting and sensitivity computation. The control algorithm uses a
physiological model of T1D to predict future blood glucose (BG) concentrations. The T1D
physiological model takes into account the dynamics between subcutaneously administered
insulin and blood glucose, the contribution of meal absorption and the lag and noise of
CGM measurements. The model parameters have been identified using prior data. Numerical
simulations on 10 patients show that the NMPC algorithm is safe and is able to optimize the
insulin delivery in patients with T1D.
Keywords: Type 1 diabetes, diabetes technology, nonlinear model predictive control,
continuous-discrete extended Kalman filter.
1. INTRODUCTION
Type 1 diabetes (T1D) is an autoimmune disease causing
the destruction of the insulin-producing β-cells of the pan-
creas. People with T1D rely on exogenously administered
insulin to regulate their blood glucose (BG) concentration.
Usual insulin therapy consists of a combination of basal
insulin and insulin boluses. Basal insulin compensates for
endogenous glucose production from the liver, whereas
boluses are administered at mealtimes to mitigate post-
prandial glucose excursions. Currently, the decision on the
amounts of insulin to administer is made by the patient
him/herself.
The artificial pancreas (AP) refers to closed-loop of BG
concentration for T1D, and has the potential to partially
or fully automate the insulin therapy for people with T1D.
Current AP prototypes comprise a CGM, a control algo-
rithm and an insulin pump. The CGM provides frequent
interstitial glucose measurements (al least every 5 minutes,
but more frequent measurements are also possible). The
estimator computes the state estimates and predictions
through an extended Kalman filter (EKF) and identifies
the parameters of the T1D model using maximum like-
lihood. The detector detects faulty CGM measurements,
eg. drifts, as well as meal time and size by using a spe-
cific algorithm for meal estimation (Turksoy et al. (2016);
Mahmoudi et al. (2016, 2017); Samadi et al. (2018)). The
MPC algorithm uses the model and states provided by the
Kalman filter and meal information to predict and opti-
mize future insulin injections. Smart bolus calculators may
be used to compute prandial insulin boluses (Marchetti
 This paper is funded by The Danish Diabetes Academy supported
by the Novo Nordisk Foundation.
et al. (2008); Schmidt et al. (2012); Boiroux et al. (2015,
2017)). A continuous subcutaneous insulin infusion (CSII)
pump implements the suggested basal and/or boluses us-
ing the subcutaneous (sc.) route. Fig. 1 illustrates the AP.
Model predictive control (MPC) is a model-based con-
trol technology. At each iteration, the control algorithm
optimizes the predicted outcome of a given system by
solving an optimal control problem (OCP). Nonlinear
model predictive control (NMPC) algorithms have al-
ready shown promising closed-loop performance in the
case where full state information is available (Boiroux
et al. (2010a)). Nonlinear filters such as the extended and
unscented Kalman filters can estimate the meal size and
track the insulin sensitivity (Boiroux et al. (2015)). The
NMPC-based approach has the advantage to incorporate
the physiological model of the patient, the constraints
on insulin injections, the insulin on board, the effects of
CHO absorption, the physiological lags and delays in an
intuitive, unified and straightforward manner.
In this paper, we present and evaluate the closed-loop
performance of a NMPC-based control algorithm for T1D
with parameters identified from prior data. The physiolog-
ical T1D is formulated as a stochastic model in continuous
time with discrete-time measurements. We assess the per-
formance of our control algorithm on a virtual population
of 10 patients with T1D.
This paper is structured as follows. Section 2 presents the
identifiable physiological model of T1D and the identified
parameters for 10 virtual patients. Section 3 presents the
continuous-discrete extended Kalman filter. In Section 4,
we briefly state the OCP used in our control algorithm.
In Section 5, we discuss the formulation of the objective
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the destruction of t e insulin-producing β-cells of the pa -
creas. People with T1D rely on exogenously administered
i s li to regulate their blood glucose (BG) concentration.
Usual i s lin therapy consists of a combination of bas l
ins lin and insuli boluses. Basal insulin co pensates for
endogenous glucose production from t liver, whereas
boluses are admi istere at m altimes to mitigate post-
prandial glucose excursions. Currently, the decision on the
amounts of insulin to administer is made by the patient
him/herself.
The artificial pancr as (AP) r fers to closed-loop of BG
conc tration f r T1D, and has the potential to partially
or fully automate the insulin therapy for e ple with T1D.
Current AP pr totypes co prise CGM, a control algo-
rithm and an insulin pump. The CGM provides frequent
interstitial glucose measurements (al least every 5 minutes,
but more fr qu t measurements are also possible). The
estim tor computes the state estimates and predictions
t rough an extended Kalman filter (EKF) and identifies
the parameters of the T1D odel using maximum lik -
lihood. The detector detects faulty CGM m asurements,
eg. drifts, as well as meal time nd size by using a spe-
cific algorithm for meal estimation (Turksoy et al. (2016);
M hmoudi t l. (2016, 2017); Samadi et al. (2018)). The
MPC algorithm uses the model and states provided by the
Kalman filter and meal information to predict and opti-
mize future insulin injections. Smart bolus calculators may
be used to compute prandial insulin boluses (Marchetti
 This paper is funded by The Danish Diabetes Academy supported
by the Novo Nordisk Foundation.
et al. (2008); Schmidt et al. (2012); Boiroux et al. (2015,
2017)). A continu s subcutaneous insulin infusion (CSII)
pump implements the suggested basal and/or boluses us-
ing the subcutaneous (sc.) route. Fig. 1 illustrates the AP.
Model predictive control (MPC) is a model-based con-
trol technology. At each iterati n, the control algorithm
optimizes the predicted outcome of a given system by
solving an optimal control problem (OCP). Nonlinear
model predictive control (NMPC) algorithms have al-
ready shown promising clos d-loop performance in the
case where full state information is available (Boiroux
et al. (2010a)). Nonlinear filters such as the extended and
unscented Kalman filters can stim te the meal size and
track the insulin sensitivity (Boiroux et al. (2015)). The
NMPC-based approach has the advantage to incorporate
the physi logical model of the patient, the constraints
on insulin injectio s, the insulin on bo rd, the effects of
CHO absorption, the physiological lags and delays in an
intuitive, unified and straightforward manner.
In this paper, we pres nt and evaluate the closed-loop
performance of a NMPC-based control algorithm for T1D
with parameters identified from prior data. Th physiolog-
ical T1D is f rmulated as a stochastic model in c ntinuous
time with discrete-time measurements. We assess the per-
formance of our control algorithm on a virtual population
of 10 patients with T1D.
This paper is structured as follows. ti 2 r s ts t
identifiable physiological model of T1D and the identified
param ters for 10 virtual patients. Secti 3 presents the
continuous-discrete extended Kalman filter. In Section 4,
we briefly state the OCP used in our control algorithm.
In Section 5, we discuss the formulation of the objective
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boluses are administered at mealti es to mitigate post-
prandial gluco e excursions. Currently, th decision on the
amounts o insulin to administer is made by the patient
him/herself.
The artificial pancreas (AP) refers to closed-loo of BG
concentrati n for T1D, and has the p tential to artially
or fully automate the insulin therapy for people with T1D.
Current AP prototypes compris a CGM, a control algo-
rithm and an in ulin pump. The CGM provides freq ent
interstitial glucose measurements (al least every 5 min tes,
but more frequent measurem nt are also possible). The
estimator computes the st te estimates and predic on
rough an xtended Kalman filt r (EKF) nd identifi s
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li ood. The detector detec s faulty CGM easure ents,
eg. drifts, as well as meal time and size b using a spe-
cific algorithm for meal estimation (Turkso et al. (2016);
ahmoudi et al. (2016, 2017); Samadi et al. (2018)). T
PC algorithm uses the model nd states provided by t e
Kalman filter and meal information to predict and opti-
mize future insulin injections. Smart bolus calculato s may
be used to compute prandial insulin boluses (Marchetti
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2017)). A conti uous subcutaneous insulin infusi n (CSII)
pump impleme ts the uggested basal and/or bolus s us-
ing the subcutaneous (sc.) route. Fig. 1 illustrates the AP.
M del predictive control (MPC) is a model-b sed con-
trol technology. At each iteration, the control algorithm
optimizes the predicted outcome of a given system by
solving an optimal control problem (OCP). Nonlinear
mo el predictive control (NMPC) algorithms have al-
rea y shown promising closed-l op performance in the
case where full state information is available (Boiroux
et al. (2010a)). Nonlin ar filters such as the extended
unscented Kalman filters can estimate he meal size a
track the insulin sensitivity (Boiroux et al. (2015)). Th
NMPC-based approach has the advantage to incorpora e
the physiologi al model of the patient, the constraints
on insulin injections, the insulin on board, th effects of
CHO absorption, the physiological lags a d delays in an
intuitive, unified and straightforward man er.
In this paper, we present and evaluate the closed-loop
performanc of a NMPC-based cont ol algorithm for T1D
with parameters identified from prior data. The physiol g-
ical T1D is formulated as a stochastic model in continuous
time with discrete-time measure ents. We assess the per-
formance of our control algorith on a virtual population
of 10 patients with T1D.
This paper is structured as follows. Section 2 presents the
identifiable physiological model of T1D a d the identified
parameters for 10 virtual patients. Sectio 3 presents the
continuous-discrete extended Kalman filter. In Section 4,
we briefly state the OCP used in our control algorithm.
In Section 5, we discuss the formulation of the objective
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1. INTRODUCTION
Type 1 diabetes (T1D) is an autoimmune disease causing
the destruction of the insulin-producing β-cells of the pan-
creas. People with T1D rely on exogenously administered
insulin to regulate their blood glucose (BG) concentration.
Usual insulin therapy consists of a combination of basal
insulin and insulin boluses. Basal insulin compensates for
endogenous glucose production from the liver, whereas
boluses are administered at mealtimes to mitigate post-
prandial glucose excursions. Currently, the decision on the
amounts of insulin to administer is made by the patient
him/herself.
The artificial pancreas (AP) refers to closed-loop of BG
concentration for T1D, and has the potential to partially
or fully automate the insulin therapy for people with T1D.
Current AP prototypes comprise a CGM, a control algo-
rithm and an insulin pump. The CGM provides frequent
interstitial glucose measurements (al least every 5 minutes,
but more frequent measurements are also possible). The
estimator computes the state estimates and predictions
through an extended Kalman filter (EKF) and identifies
the parameters of the T1D model using maximum like-
lihood. The detector detects faulty CGM measurements,
eg. drifts, as well as meal time and size by using a spe-
cific algorithm for meal estimation (Turksoy et al. (2016);
Mahmoudi et al. (2016, 2017); Samadi et al. (2018)). The
MPC algorithm uses the model and states provided by the
Kalman filter and meal information to predict and opti-
mize future insulin injections. Smart bolus calculators may
be used to compute prandial insulin boluses (Marchetti
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et al. (2008); Schmidt et al. (2012); Boiroux et al. (2015,
2017)). A continuous subcutaneous insulin infusion (CSII)
pump implements the suggested basal and/or boluses us-
ing the subcutaneous (sc.) route. Fig. 1 illustrates the AP.
Model predic ive control (MPC) s a model-based con-
trol technology. At each iteration, the control algorithm
optimizes the predicted outcome of a given system by
solving an optimal control problem (OCP). Nonlinear
model predictive control (NMPC) algorithms have al-
ready shown promising closed-loop performance in the
case where full state information is available (Boiroux
et al. (2010a)). Nonlinear filters such as the extended and
unscented Kalman filters can estimate the meal size and
track the insulin sensitivity (Boiroux et al. (2015)). The
NMPC-based approach has the advantage to incorporate
the physiological model of the patient, the constraints
on insulin injections, the insulin on board, the effects of
CHO absorption, the physiological lags and delays in an
intuitive, unified and straightforward manner.
I th s paper, we present and evaluate the closed-loop
performance of a NMPC-based control algorithm for T1D
with parameters identified from prior data. The physiolog-
ical T1D is formulated as a stochastic model in continuous
time with discrete-time measurements. We assess the per-
formance of our control algorithm on a virtual population
of 10 patients with T1D.
This paper is structured as follows. Section 2 presents the
identifiable physiological model of T1D and the identified
parameters for 10 virtual patients. Section 3 presents the
continuous-discrete extended Kalman filter. In Section 4,
we briefly state the OCP used in our control algorithm.
In Section 5, we discuss the formulation of the objective
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Fig. 1. Diagram of the artificial pancreas. The estimator
uses an EKF to estimate states, parameters, and to
compute the state predictions. The detector estimates
the meals times and size and detects the CGM drifts
based on the identified model and innovations pro-
vided by the estimator. The MPC algorithm optimizes
the future insulin injections and computes the state
predictions.
function. Section 6 illustrates the closed-loop performance
of our control algorithm on a population of 10 patients.
Section 7 summarizes the main contribution of this paper.
2. PHYSIOLOGICAL MODEL OF
GLUCOSE-INSULIN DYNAMICS
In this section, we present a minimal physiological model
derived from the model by Kanderian et al. (2009). This
model describes the glucose-insulin dynamics, the meal
absorption, and the lag and noise from CGMs. Fig. 2 illus-
trates the MVP model. The CGM noise model has been
developed by Facchinetti et al. (2014). We add diffusion
terms to reformulate the MVP model as a stochastic model
in the form
dx(t) = f(t, x(t), u(t), d(t), θ)dt+ σ(θ)dw(t), (1a)
yk = g(xk) + vk, (1b)
in which x(t) ∈ Rnx is a vector containing the states
variables, and yk ∈ Rny is a vector containing the output
variables measured at discrete times. u(t) ∈ Rnu is a
vector containing the manipulated inputs, and d(t) ∈
Rnd is a vector containing the uncontrolled disturbances.
{w(t), t ≥ 0} is a standard Wiener process, i.e. dw(t) ∼
N(0, Idt). θ ∈ Rnθ is a vector containing the parameters
to be estimated. The matrix σ(θ) is time-invariant and
assumed to be diagonal. The measurement noise, vk, is
independently normally distributed, vk ∼ Niid(0, R(θ)).
Also, we assume that the initial state, x0, is normally
distributed with a known mean and covariance, x0 ∼
N(xˆ0|−1(θ), P0|−1(θ)).
2.1 Insulin Absorption Subsystem
The insulin absorption subsystem is given by the following
two-compartment model
dISC = k1
(
u(t)
CI
− ISC(t)
)
dt+ σ1dω1, (2a)
dIP = k2 (ISC(t)− IP (t)) dt+ σ2dω2, (2b)
where ISC(t) [mU/L/min] is the subcutaneous insulin
concentration, and IP (t) [mU/L] is the plasma insulin
concentration. u(t) [mU/min] is the insulin infusion rate,
CI [L/min] is the clearance rate.
Isc
Ieff
GD2
Ip
D1 GI
u(t)
CGM
d(t)
CHO subsystem
RA(t)
Glucose-insulin
subsystem
Sc. insulin 
subsystem
Fig. 2. The MVP model. This model simulates the ac-
tion of subcutaneously administered insulin on BG
concentration, the effects of meals, interstitial glucose
and CGM measurements.
2.2 Insulin-Glucose Dynamics
The effect of insulin on blood glucose is described by the
following SDEs
dIEFF = (−p2IEFF (t) + p2SIIP (t)) dt+ σ3dω3, (2c)
dG = (−(IEFF (t) +GEZI)G(t)+
EGP +RA(t))dt+ σ4dω4. (2d)
IEFF (t) [min
−1] is the effect of insulin. SI [mL/mU] re-
flects the insulin sensitivity. The glucose concentration
G(t) [mg/dL] is also affected by the endogenous glucose
production (EGP ) [mg/dL/min] and the rate of appear-
ance contribution from the meals, RA(t) [mg/dL/min].
2.3 CHO Absorption Model
We use the two-compartment model introduced by Hov-
orka et al. Hovorka et al. (2004) to describe the carbo-
hydrates (CHO) absorption from meals and conversion to
glucose. The model describes the effect of orally ingested
carbohydrates on the rate of appearance of glucose RA(t)
[mg/dL/min] in the blood stream. The CHO absorption
model is
dD1 =
(
d(t)− D1(t)
τG
)
dt+ σ5dω5, (2e)
dD2 =
(
D1(t)−D2(t)
τG
)
dt+ σ6dω6, (2f)
RA(t) = D2(t)
km
VG
. (2g)
d(t) [mg/min] is the meal intake. km [min] is the inverse
of the meal absorption time constant and VG [dL
−1] is the
glucose distribution volume.
2.4 CGM Model
We use here the CGMmodel from Facchinetti et al. (2014).
This model represents the glucose transport from plasma
to interstitial tissues and the sensor noise. The equation
describing glucose transport is
dGI =
1
τG,I
(G(t)−GI(t)) dt+ σ7dω7, (2h)
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Fig. 3. Example of dataset used for identification.
where the time constant τG,I is 6.7 min. The sensor noise is
represented by the sum of the two following autoregressive
processes
cck = 1.23cck−1 − 0.3995cck−2 + wcc,k, (3a)
vˆk = 1.013vˆk−1 − 0.2135vˆk−2 + wk, (3b)
in which wcc,k ∼ N(0,11.3 mg2/dL2) and wk ∼ N(0,14.45
mg2/dL2). Thus, the discrete noise-corrupted value re-
turned by the glucose sensor and used in (1b) at the time
tk is
yk = GI(tk) + cck + vˆk. (4)
2.5 Model identification
The terms related to time constants, k1, k2 and p2, as
well as the glucose effectiveness at zero insulin, GEZI, are
highly uncertain. Therefore, based on our previous work
and these observations in Boiroux et al. (2016), we suggest
the following simplifications: (i) We use only one term to
describe the inverse of the time constants, k1, k2 and p2,
(ii) we fix the insulin clearance rate, CI , because it cannot
be distinguished from the insulin sensitivity when only
CGM measurements are available, (iii) we set GEZI = 0
and (iv) we only identify the diffusion term related to
blood glucose concentration, σ4.
We identify the model parameters in our model using max-
imum likelihood combined with the continuous-discrete
extended Kalman filter described in the next section (Kris-
tensen et al. (2004)). The full details regarding the model
identification are provided in Boiroux et al. (2018). Table 1
provides a summary of the identified model parameters for
the 10 virtual patients. Fig. 3 shows the BG concentration
and CGM measurements, the insulin concentration and
the sc. insulin concentration for Patient 1.
3. CONTINUOUS-DISCRETE EXTENDED KALMAN
FILTER
The CDEKF is used for state estimation of continuous-
discrete grey-box models (Jazwinski (1970); Nørgaard
et al. (2000)). In this paper, we use the CDEKF for model
identification and in the control algorithm. The filtering
in the CDEKF describes the steps used to compute the
filtered state, xˆk|k, and the corresponding covariance, Pk|k.
The filter step assumes availability of the one-step predic-
tions, xˆk|k−1 and Pk|k−1.
The predictive filter gain is computed by
Re,k = CkPk|k−1C ′k +R, (5a)
Kk = Pk|k−1C ′kR
−1
e,k, (5b)
and the innovation is obtained by
ek = yk − Ckxˆk|k−1, (6)
where
Ck =
∂g
∂x
(xˆk|k−1) (7)
provides a linearization of the output function g evaluated
at xˆk|k−1.
The filtered state, xˆk|k, and its covariance Pk|k are given
by
xˆk|k = xˆk|k−1 +Kkek (8a)
Pk|k = Pk|k−1 −KkRe,kK ′k. (8b)
The predicted mean-covariance pair of the state estimate,
xˆk+1|k = xˆk(tk+1) and Pk+1|k = Pk(tk+1), is computed as
the solution to the system of coupled ordinary differential
equations (Jørgensen and Jørgensen (2007))
dxˆk(t)
dt
= f(t, xˆk(t), uk), (9a)
dPk(t)
dt
= Ak(t)Pk(t) + Pk(t)Ak(t)
′ + σσ′, (9b)
with
Ak(t) = A(t, xˆk(t), uk) =
∂f
∂x
(t, xˆk(t), uk). (10)
The initial conditions for (9a)-(9b) are
xˆk(tk) = xˆk|k, (11a)
Pk(tk) = Pk|k. (11b)
4. OPTIMAL CONTROL PROBLEM
We assume a zero-order hold parametrization of the input
vector, u(t) and the disturbance vector, d(t). At each
iteration, the NMPC algorithm will have to solve an
optimal control problem in the form
min
{xk+1,uk}N−1k=0
φ =
N−1∑
k=0
Gk(xk, uk, dk) + h(xN ) (12a)
s.t. bk := Fk(xk, uk, dk)− xk+1 = 0, (12b)
x(t0) = x0, (12c)
umin ≤ uk ≤ umax. (12d)
The function describing the state dynamics is
Fk(xk, uk, dk) = {x(tk+1) : x˙(t) = f(x(t), uk, dk),
x(tk) = xk}. (13)
The discrete time stage cost is
Gk(xk, uk, dk) = {
∫ tk+1
tk
g(x(t), uk)dt :
x˙(t) = f(x(t), uk, dk), x(tk) = xk}. (14)
In this paper, we use a multiple-shooting based sequential
quadratic programming (SQP) algorithm (Bock and Plitt
(1984); Diehl et al. (2009); Boiroux et al. (2010a)). The
SQP algorithm is used for the numerical solution of (12).
We use an explicit Runge-Kutta scheme with fixed stepsize
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where the time constant τG,I is 6.7 min. The sensor noise is
represented by the sum of the two following autoregressive
processes
cck = 1.23cck−1 − 0.3995cck−2 + wcc,k, (3a)
vˆk = 1.013vˆk−1 − 0.2135vˆk−2 + wk, (3b)
in which wcc,k ∼ N(0,11.3 mg2/dL2) and wk ∼ N(0,14.45
mg2/dL2). Thus, the discrete noise-corrupted value re-
turned by the glucose sensor and used in (1b) at the time
tk is
yk = GI(tk) + cck + vˆk. (4)
2.5 Model identification
The terms related to time constants, k1, k2 and p2, as
well as the glucose effectiveness at zero insulin, GEZI, are
highly uncertain. Therefore, based on our previous work
and these observations in Boiroux et al. (2016), we suggest
the following simplifications: (i) We use only one term to
describe the inverse of the time constants, k1, k2 and p2,
(ii) we fix the insulin clearance rate, CI , because it cannot
be distinguished from the insulin sensitivity when only
CGM measurements are available, (iii) we set GEZI = 0
and (iv) we only identify the diffusion term related to
blood glucose concentration, σ4.
We identify the model parameters in our model using max-
imum likelihood combined with the continuous-discrete
extended Kalman filter described in the next section (Kris-
tensen et al. (2004)). The full details regarding the model
identification are provided in Boiroux et al. (2018). Table 1
provides a summary of the identified model parameters for
the 10 virtual patients. Fig. 3 shows the BG concentration
and CGM measurements, the insulin concentration and
the sc. insulin concentration for Patient 1.
3. CONTINUOUS-DISCRETE EXTENDED KALMAN
FILTER
The CDEKF is used for state estimation of continuous-
discrete grey-box models (Jazwinski (1970); Nørgaard
et al. (2000)). In this paper, we use the CDEKF for model
identification and in the control algorithm. The filtering
in the CDEKF describes the steps used to compute the
filtered state, xˆk|k, and the corresponding covariance, Pk|k.
The filter step assumes availability of the one-step predic-
tions, xˆk|k−1 and Pk|k−1.
The predictive filter gain is computed by
Re,k = CkPk|k−1C ′k +R, (5a)
Kk = Pk|k−1C ′kR
−1
e,k, (5b)
and the innovation is obtained by
ek = yk − Ckxˆk|k−1, (6)
where
Ck =
∂g
∂x
(xˆk|k−1) (7)
provides a linearization of the output function g evaluated
at xˆk|k−1.
The filtered state, xˆk|k, and its covariance Pk|k are given
by
xˆk|k = xˆk|k−1 +Kkek (8a)
Pk|k = Pk|k−1 −KkRe,kK ′k. (8b)
The predicted mean-covariance pair of the state estimate,
xˆk+1|k = xˆk(tk+1) and Pk+1|k = Pk(tk+1), is computed as
the solution to the system of coupled ordinary differential
equations (Jørgensen and Jørgensen (2007))
dxˆk(t)
dt
= f(t, xˆk(t), uk), (9a)
dPk(t)
dt
= Ak(t)Pk(t) + Pk(t)Ak(t)
′ + σσ′, (9b)
with
Ak(t) = A(t, xˆk(t), uk) =
∂f
∂x
(t, xˆk(t), uk). (10)
The initial conditions for (9a)-(9b) are
xˆk(tk) = xˆk|k, (11a)
Pk(tk) = Pk|k. (11b)
4. OPTIMAL CONTROL PROBLEM
We assume a zero-order hold parametrization of the input
vector, u(t) and the disturbance vector, d(t). At each
iteration, the NMPC algorithm will have to solve an
optimal control problem in the form
min
{xk+1,uk}N−1k=0
φ =
N−1∑
k=0
Gk(xk, uk, dk) + h(xN ) (12a)
s.t. bk := Fk(xk, uk, dk)− xk+1 = 0, (12b)
x(t0) = x0, (12c)
umin ≤ uk ≤ umax. (12d)
The function describing the state dynamics is
Fk(xk, uk, dk) = {x(tk+1) : x˙(t) = f(x(t), uk, dk),
x(tk) = xk}. (13)
The discrete time stage cost is
Gk(xk, uk, dk) = {
∫ tk+1
tk
g(x(t), uk)dt :
x˙(t) = f(x(t), uk, dk), x(tk) = xk}. (14)
In this paper, we use a multiple-shooting based sequential
quadratic programming (SQP) algorithm (Bock and Plitt
(1984); Diehl et al. (2009); Boiroux et al. (2010a)). The
SQP algorithm is used for the numerical solution of (12).
We use an explicit Runge-Kutta scheme with fixed stepsize
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Table 1. Numerical value of the estimated parameters for the 10 patients.
Patient k1, k2, p2 SI EGP0 1/VG km σ4 k1/km
(min−1) (mL/mU/min) (mg/dL/min) (dL−1) (min−1) (mg/dL/min) (-)
1 0.023 0.0017 1.17 0.0082 0.0226 2.91 1.02
2 0.015 0.0011 0.98 0.004 0.022 3.15 0.68
3 0.021 0.0014 0.87 0.007 0.026 3.15 0.81
4 0.018 0.0019 1.47 0.0059 0.018 3.07 1.00
5 0.012 0.0024 1.57 0.021 0.015 3.28 0.80
6 0.012 0.0018 1.49 0.0020 0.014 3.60 0.86
7 0.014 0.0016 1.07 0.013 0.017 3.13 0.82
8 0.016 0.0011 0.94 0.0036 0.040 3.08 0.44
9 0.014 0.0005 0.35 0.0044 0.041 2.78 0.34
10 0.017 0.0008 0.67 0.0039 0.034 3.14 0.50
Mean 0.017 0.0013 0.958 0.0074 0.027 3.05 0.63
for the numerical integration of the state dynamics, the
objective function and for computation of the sensitivities
of the objective function and the constraints. The initial
state, x0, is estimated by the CDEKF.
4.1 SQP algorithm
We define the parameter vector, p, as
p =
[
u′0 x
′
1 u
′
1 x
′
2 . . . x
′
N−1 u
′
N−1 x
′
N
]′
. (15)
We compute the residuals as
b(p) = b(p, x0, d)
=

F0(x0, u0, d0)− x1
F1(x1, u1, d1)− x2
...
FN−1(xN−1, uN−1, dN−1)− xN
 . (16)
Using these notations, we reformulate the discrete-time
OCP (12) as a constrained optimization problem in the
standard SQP form
min
p
φ = φ(p) =
N−1∑
k=0
Gk(xk, uk, d) + h(xN ), (17a)
s.t. b(p) = 0, (17b)
c(p) ≥ 0, (17c)
in which c(p) corresponds to the bound constraints
umin ≤ uk ≤ umax. (18)
5. OBJECTIVE FUNCTION
In this section, we present and discuss the choice of the
objective function. The objective function, φ, is a function
of the BG concentration, z(t), and the variations in insulin
infusion rates, ∆uk. It is
φ =
BG penalty function︷ ︸︸ ︷∫ tf
t0
ρz(z(t))dt +
Insulin penalty term︷ ︸︸ ︷
ρ∆u(∆uk) . (19)
The BG penalty function penalizes the deviation of the
predicted BG concentration, z(t), to a given setpoint, z¯.
The quadratic glucose penalty function are defined as
ρz¯(z) =
1
2
(z − z¯)2, (20a)
ρzmin(z) =
1
2
(min {z − zmin, 0})2 , (20b)
ρzmax(z) =
1
2
(max {z − zmax, 0})2 , (20c)
Fig. 4. The asymmetric penalty function.
where z¯ is the desired glucose target. zmin and zmax are
thresholds for hypoglycemia (BG<70 mg/dL) and hyper-
glycemia (BG>180 mg/dL), respectively. The resulting
penalty function is
ρz(z) = αz¯ρz¯(z) + αzminρzmin(z) + αzmaxρzmax(z), (21)
in which αz¯, αzmin and αzmax are weights. Since hypo-
glycemia is much more undesirable than hyperglycemia
and postprandial hyperglycemia is unavoidable, we set
high penalties for BG concentrations below 4 mmol/L and
we do not set any additional penalty on hyperglycemic
BG concentrations, ie. αzmax = 0. Fig. 4 illustrates the
asymmetrical cost function.
It is possible to normalize the weight on the 2 penalty for
∆u by setting the following scaling
ρ∆u(∆u) =
1
2
α∆u
Ts
∆u2, (22a)
in which Ts is the sampling time, such that the tuning of
the controller remains identical regardless of the sampling
time.
6. RESULTS
In this section, we evaluate the closed-loop performance of
our NMPC-based control algorithm using numerical simu-
lations of a stochastic model. To simulate the intra-patient
variability, we consider a SDE version of the T1D model
in the form of (1). The model for simulation is derived
from the model and the parameter distribution developed
by (Hovorka et al., 2002). We use the Euler-Maruyama
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(a) BG concentration profile (top) and sc. insulin administration
profile (bottom).
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Fig. 5. BG concentration and insulin traces for the 10
virtual patients.
method for numerical integration, see eg. Higham (2001).
The patients have the following meals: a 75g CHO break-
fast at 6:00, a 100g CHO lunch at 12:00 and a 75g CHO
dinner at 18:00. The meals are announced to the controller
at mealtimes only. We set umin = 0 to allow insulin
suspension and we set the maximal insulin infusion rate,
umax, to a large value such that it is not limiting the
performance of the control algorithm.
Fig. 5 shows the BG concentration traces and the insulin
infusion rates for the 10 virtual patients. The variability
between the patients becomes large after meals, depending
on the sc. insulin and meal absorption time constants. The
insulin profile shows a bolus-like impulse followed by a
suspension of insulin delivery for all patients, sometimes
referred to as a super-bolus. Clinical studies have shown
that using a super-bolus strategy tightens the regulation of
BG concentration and reduces the occurrence of postpran-
dial hypoglycemia (Rossetti et al. (2012); Boronat et al.
(2015)).
Fig. 6 depicts the control variability grid analysis (CVGA)
plot for the 10 patients. Only one patient had a mild hy-
poglycemic event before breakfast. The large postprandial
glucose excursions are mainly caused by the large meal
sizes and the ratio between time-to-peak of meal absorp-
tion and time-to-peak of insulin absorption (Boiroux et al.
(2010b); El Fathi et al. (2018)).
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Fig. 6. Control variability grid analysis (CVGA) for the 10
virtual patients (Magni et al. (2008)).
Table 2. Percentage of time spent in different
BG concentration ranges. The numbers show
the median and the interquartile range (IQR).
Median IQR
BG > 180 mg/dL (%) 16.6 9.0-25.3
70 ≤ BG ≤ 180 mg/dL (%) 82.2 74.7-91.0
70 ≤ BG ≤ 140 mg/dL (%) 73.0 61.8-81.3
BG < 70 mg/dL (%) 0 0-0
The simulation results provide insight into the ideal insulin
delivery profile and the maximum achievable performance
of an AP system. For patients with elevated postprandial
peaks, safety considerations would preclude from adminis-
tering large amounts of insulin ahead of meals. Instead, an
adapted diet consisting of lower CHO amounts and slower
sugars could reduce postprandial glucose excursions.
Table 2 shows the BG concentration median percentage of
time spent in target, hypo- and hyperglycemia. The table
shows the median and interquartile range. We see that
most of the time is spent in euglycemic range. However,
the time spent in hyperglycemia varies and highly depends
on the meal and insulin absorption dynamics.
7. CONCLUSION
In this paper we developed an NMPC-based control al-
gorithm. Parameter identification is used to handle inter-
patient variability and to adjust for long-term metabolic
variations. We numerically evaluated the performance of
our control algorithm. The results suggest that the estima-
tion of model parameters involved in NMPC algorithms
using CGM data is promising for the design of an AP.
Currently, the slow insulin dynamics compared to CHO
absorption dynamics limit the performance of the AP.
Personalized diet in complement to control algorithms
could further improve glucose regulation by reducing post-
prandial peaks.
REFERENCES
Bock, H. and Plitt, K. (1984). A multiple shooting method
for direct solution of optimal control problems. In Proc.
IFAC BMS 2018
São Paulo, Brazil, September 3-5, 2018
196
 Dimitri Boiroux  et al. / IFAC PapersOnLine 51-27 (2018) 192–197 197
(a) BG concentration profile (top) and sc. insulin administration
profile (bottom).
00:00 06:00 12:00 18:00 00:00
Time [hr]
0
20
40
In
su
lin
 [m
U/
mi
n]
(b) Zoom on the insulin administration profile.
Fig. 5. BG concentration and insulin traces for the 10
virtual patients.
method for numerical integration, see eg. Higham (2001).
The patients have the following meals: a 75g CHO break-
fast at 6:00, a 100g CHO lunch at 12:00 and a 75g CHO
dinner at 18:00. The meals are announced to the controller
at mealtimes only. We set umin = 0 to allow insulin
suspension and we set the maximal insulin infusion rate,
umax, to a large value such that it is not limiting the
performance of the control algorithm.
Fig. 5 shows the BG concentration traces and the insulin
infusion rates for the 10 virtual patients. The variability
between the patients becomes large after meals, depending
on the sc. insulin and meal absorption time constants. The
insulin profile shows a bolus-like impulse followed by a
suspension of insulin delivery for all patients, sometimes
referred to as a super-bolus. Clinical studies have shown
that using a super-bolus strategy tightens the regulation of
BG concentration and reduces the occurrence of postpran-
dial hypoglycemia (Rossetti et al. (2012); Boronat et al.
(2015)).
Fig. 6 depicts the control variability grid analysis (CVGA)
plot for the 10 patients. Only one patient had a mild hy-
poglycemic event before breakfast. The large postprandial
glucose excursions are mainly caused by the large meal
sizes and the ratio between time-to-peak of meal absorp-
tion and time-to-peak of insulin absorption (Boiroux et al.
(2010b); El Fathi et al. (2018)).
110 90 70 50 
Minimum Glucose Concentration [mg/dL]
400
300
180
110M
ax
im
um
 G
lu
co
se
 C
on
ce
nt
ra
tio
n 
[m
g/d
L]
Fig. 6. Control variability grid analysis (CVGA) for the 10
virtual patients (Magni et al. (2008)).
Table 2. Percentage of time spent in different
BG concentration ranges. The numbers show
the median and the interquartile range (IQR).
Median IQR
BG > 180 mg/dL (%) 16.6 9.0-25.3
70 ≤ BG ≤ 180 mg/dL (%) 82.2 74.7-91.0
70 ≤ BG ≤ 140 mg/dL (%) 73.0 61.8-81.3
BG < 70 mg/dL (%) 0 0-0
The simulation results provide insight into the ideal insulin
delivery profile and the maximum achievable performance
of an AP system. For patients with elevated postprandial
peaks, safety considerations would preclude from adminis-
tering large amounts of insulin ahead of meals. Instead, an
adapted diet consisting of lower CHO amounts and slower
sugars could reduce postprandial glucose excursions.
Table 2 shows the BG concentration median percentage of
time spent in target, hypo- and hyperglycemia. The table
shows the median and interquartile range. We see that
most of the time is spent in euglycemic range. However,
the time spent in hyperglycemia varies and highly depends
on the meal and insulin absorption dynamics.
7. CONCLUSION
In this paper we developed an NMPC-based control al-
gorithm. Parameter identification is used to handle inter-
patient variability and to adjust for long-term metabolic
variations. We numerically evaluated the performance of
our control algorithm. The results suggest that the estima-
tion of model parameters involved in NMPC algorithms
using CGM data is promising for the design of an AP.
Currently, the slow insulin dynamics compared to CHO
absorption dynamics limit the performance of the AP.
Personalized diet in complement to control algorithms
could further improve glucose regulation by reducing post-
prandial peaks.
REFERENCES
Bock, H. and Plitt, K. (1984). A multiple shooting method
for direct solution of optimal control problems. In Proc.
IFAC BMS 2018
São Paulo, Brazil, September 3-5, 2018
196
of the IFAC 9th World Congress, 242–247. Budapest,
Hungary.
Boiroux, D., Arado´ttir, T., Hagdrup, M., Poulsen, N.,
Madsen, H., and Jørgensen, J.B. (2015). A bolus cal-
culator based on continuous-discrete unscented Kalman
filtering for type 1 diabetics. In 9th IFAC Symposium
on Biological and Medical Systems, 159 – 164.
Boiroux, D., Finan, D.A., Poulsen, N.K., Madsen, H., and
Jørgensen, J.B. (2010a). Nonlinear model predictive
control for an artificial β-cell. In Recent Advances in
Optimization and its Applications in Engineering, 299 –
308. Springer.
Boiroux, D., Finan, D.A., Poulsen, N.K., Madsen, H., and
Jørgensen, J.B. (2010b). Optimal insulin administration
for people with type 1 diabetes. In Proceedings of the
9th International Symposium on Dynamics and Control
of Process Systems (DYCOPS 2010), 234 – 239.
Boiroux, D., Arado´ttir, T.B., Nørgaard, K., Poulsen, N.K.,
Madsen, H., and Jørgensen, J.B. (2017). An adaptive
nonlinear basal-bolus calculator for patients with type
1 diabetes. Journal of Diabetes Science and Technology,
11(1), 29–36.
Boiroux, D., Hagdrup, M., Mahmoudi, Z., Poulsen, N.K.,
Madsen, H., and Jørgensen, J.B. (2016). Model iden-
tification using continuous glucose monitoring data for
type 1 diabetes. IFAC-PapersOnLine, 49(7), 759–764.
Boiroux, D., Mahmoudi, Z., and Jørgensen, J.B. (2018).
Parameter estimation in type 1 diabetes models for
model-based control applications. In 2018 IEEE
Conference on Control Technology and Applications
(CCTA2018). Submitted.
Boronat, M., Sa´nchez-Herna´ndez, R.M., Rodr´ıguez-
Cordero, J., Jime´nez-Ortega, A., and No´voa, F.J.
(2015). Suspension of basal insulin to avoid hypo-
glycemia in type 1 diabetes treated with insulin pump.
Endocrinology, Diabetes & Metabolism Case Reports,
2015.
Diehl, M., Ferreau, J., and Haverbeke, N. (2009). Effi-
cient numerical methods for nonlinear MPC and moving
horizon estimation. In Nonlinear Model Predictive Con-
trol. Towards New Challenging Applications, 391–417.
Springer, Berlin, Germany.
El Fathi, A., Smaoui, M.R., Gingras, V., Boulet, B., and
Haidar, A. (2018). The artificial pancreas and meal
control: An overview of postprandial glucose regulation
in type 1 diabetes. IEEE Control Systems Magazine,
38(1), 67–85.
Facchinetti, A., Del Favero, S., Sparacino, G., Castle, J.R.,
Ward, W.K., and Cobelli, C. (2014). Modeling the
glucose sensor error. IEEE Transactions on Biomedical
Engineering, 61(3), 620–629.
Higham, D.J. (2001). An algorithmic introduction to
numerical simulation of stochastic differential equations.
SIAM Review, 43(3), 525–546.
Hovorka, R., Canonico, V., Chassin, L.J., Haueter, U.,
Massi-Benedetti, M., Federici, M.O., Pieber, T.R.,
Schaller, H.C., Schaupp, L., Vering, T., and Wilinska,
M.E. (2004). Nonlinear model predictive control of
glucose concentration in subjects with type 1 diabetes.
Physiological Measurement, 25, 905–920.
Hovorka, R., Shojaee-Moradie, F., Caroll, P.V., Chassin,
L.J., Gowrie, I.J., Jackson, N.C., Tudor, R.S., Umpleby,
A.M., and Jones, R.H. (2002). Partitioning glucose dis-
tribution/transport, disposal, and endogenous produc-
tion during IVGTT. American Journal of Physiology,
282, 992–1007.
Jazwinski, A.H. (1970). Stochastic Processes and Filtering
Theory. Academic Press, San Diego, CA.
Jørgensen, J.B. and Jørgensen, S.B. (2007). Comparison of
prediction-error modelling criteria. In Proceedings of the
2007 American Control Conference (ACC 2007), 140–
146.
Kanderian, S.S., Weinzimer, S., Voskanyan, G., and Steil,
G.M. (2009). Identification of intraday metabolic pro-
files during closed-loop glucose control in individuals
with type 1 diabetes. Journal of Diabetes Science and
Technology, 3(5), 1047 – 1057.
Kristensen, N.R., Madsen, H., and Jørgensen, S.B. (2004).
Parameter estimation in stochastic grey-box models.
Automatica, 40, 225 – 237.
Magni, L., Raimondo, D., Man, C.D., Breton, M., Patek,
S., Nicolao, G.D., Cobelli, C., and Kovatchev, B. (2008).
Evaluating the efficacy of closed-loop glucose regulation
via control-variability grid analysis. Journal of Diabetes
Science and Technology, 2(4), 630 – 635.
Mahmoudi, Z., Boiroux, D., Hagdrup, M., Kj, N., Madsen,
H., Bagterp, J., et al. (2016). Application of the
continuous-discrete extended Kalman filter for fault
detection in continuous glucose monitors for type 1
diabetes. In 2016 European Control Conference (ECC
2016), 714–719.
Mahmoudi, Z., Nørgaard, K., Poulsen, N.K., Madsen, H.,
and Jørgensen, J.B. (2017). Fault and meal detection
by redundant continuous glucose monitors and the un-
scented Kalman filter. Biomedical Signal Processing and
Control, 38, 86–99.
Marchetti, G., Barolo, M., Jovanovicˇ, L., Zisser, H., and
Seborg, D.E. (2008). A feedforward-feedback glucose
control strategy for type 1 diabetes mellitus. Journal of
Process Control, 18(2), 149–162.
Nørgaard, M., Poulsen, N.K., and Ravn, O. (2000). New
developments in state estimation for nonlinear systems.
Automatica, 36, 1627–1638.
Rossetti, P., Ampudia-Blasco, F.J., Laguna, A., Revert,
A., Veh`ı, J., Ascaso, J.F., and Bondia, J. (2012). Eval-
uation of a novel continuous glucose monitoring-based
method for mealtime insulin dosingthe ibolusin subjects
with type 1 diabetes using continuous subcutaneous
insulin infusion therapy: a randomized controlled trial.
Diabetes Technology & Therapeutics, 14(11), 1043–1052.
Samadi, S., Rashid, M., Turksoy, K., Feng, J., Hajizadeh,
I., Hobbs, N., Lazaro, C., Sevil, M., Littlejohn, E., and
Cinar, A. (2018). Automatic detection and estimation of
unannounced meals for multivariable artificial pancreas
system. Diabetes Technology & Therapeutics, 20(3),
DOI: 10.1089/dia.2017.0364.
Schmidt, S., Meldgaard, M., Serifovski, N., Storm, C.,
Christensen, T.M., Gade-Rasmussen, B., and Nørgaard,
K. (2012). Use of an automated bolus calculator in MDI-
treated type 1 diabetes. Diabetes Care, 35(5), 984–990.
Turksoy, K., Samadi, S., Feng, J., Littlejohn, E., Quinn,
L., and Cinar, A. (2016). Meal detection in patients
with type 1 diabetes: a new module for the multivariable
adaptive artificial pancreas control system. IEEE Jour-
nal of Biomedical and Health Informatics, 20(1), 47–54.
IFAC BMS 2018
São Paulo, Brazil, September 3-5, 2018
197
